Prepulse inhibition: Difference between revisions
CSV import |
CSV import |
||
| Line 31: | Line 31: | ||
[[Category:Neuroscience]] | [[Category:Neuroscience]] | ||
[[Category:Psychophysiology]] | [[Category:Psychophysiology]] | ||
<gallery> | |||
File:Prepulse_Inhibition_schematically.png|Diagram illustrating the concept of prepulse inhibition | |||
File:Startle_Imetronic.jpg|Equipment used for measuring startle response | |||
File:Matt's_PhD_Study.jpg|Research setup for studying prepulse inhibition | |||
</gallery> | |||
Latest revision as of 01:43, 18 February 2025
Prepulse inhibition (PPI) is a neurological phenomenon in which a weaker pre-stimulus (or prepulse) inhibits the reaction of an organism to a subsequent strong startling stimulus (pulse). The reduction of the amplitude of startle reflects the ability of the nervous system to temporarily adapt to a strong sensory stimulus when a preceding weaker signal is given to warn the organism. This process is thought to measure the sensory gating capacity of neural circuits, and is used as a research tool in psychophysiological research to understand the role of inhibitory processes in normal and abnormal cognitive function.
Mechanism[edit]
The mechanism of PPI is not fully understood, but it is known to involve a network of brain regions including the auditory system, the limbic system, and the frontal cortex. The prepulse stimulus is thought to activate inhibitory interneurons in these regions, which then inhibit the response to the subsequent startling stimulus.
Clinical significance[edit]
PPI is often reduced in individuals with certain neurological and psychiatric disorders, such as schizophrenia, bipolar disorder, and Parkinson's disease. This reduction in PPI is thought to reflect a deficit in sensory gating, which may contribute to the cognitive and perceptual disturbances associated with these disorders.
Research[edit]
Research on PPI has provided insights into the neural mechanisms underlying sensory gating and has potential implications for the development of new treatments for disorders characterized by sensory gating deficits.
See also[edit]
References[edit]
<references />


